BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10731949)

  • 1. [Clinical manifestation of toxic pancreas lesion in children with hematopoietic malignancies].
    Balcerska A; Maciejka-Kapuścińska L; Kosiak W
    Wiad Lek; 1998; 51 Suppl 4():90-6. PubMed ID: 10731949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide therapy in asparaginase-associated pancreatitis in childhood acute lymphoblastic leukemia.
    Wu SF; Chen AC; Peng CT; Wu KH
    Pediatr Blood Cancer; 2008 Dec; 51(6):824-5. PubMed ID: 18726919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase].
    Wlazłowski M; Celińska W; Maciejka-Kapuścińska L; Płoszyńska A; Idczak E
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):296-7. PubMed ID: 7808958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient hyperammonemia due to L-asparaginase therapy in children with acute lymphoblastic leukemia or non-Hodgkin lymphoma.
    Jörck C; Kiess W; Weigel JF; Mütze U; Bierbach U; Beblo S
    Pediatr Hematol Oncol; 2011 Feb; 28(1):3-9. PubMed ID: 20615069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic panniculitis caused by L-asparaginase induced acute pancreatitis in a child with acute lymphoblastic leukemia.
    Chiewchengchol D; Wananukul S; Noppakun N
    Pediatr Dermatol; 2009; 26(1):47-9. PubMed ID: 19250405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute pancreatitis secondary to L-asparaginase (a case report)].
    Tazi I; Rachid M; Quessar A; Harif M; Benchekroun S
    East Mediterr Health J; 2009; 15(2):475-9. PubMed ID: 19554997
    [No Abstract]   [Full Text] [Related]  

  • 7. [Severe acute pancreatitis in children receiving asparaginase: multicenter retrospective study].
    Laugel V; Escande B; Entz-Werle N; Mazingue F; Ferster A; Bertrand Y; Missud F; Lutz P
    Arch Pediatr; 2005 Jan; 12(1):34-41. PubMed ID: 15653052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of L-asparaginase activity and biochemical parameters evaluation in children with acute lymphoblastic leukemia].
    Pawińska K; Balwierz W; Sztefko K; Czogała M
    Przegl Lek; 2006; 63(1):44-6. PubMed ID: 16892900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful management of severe L-asparaginase-associated pancreatitis by continuous regional arterial infusion of protease inhibitor and antibiotic.
    Morimoto A; Imamura T; Ishii R; Nakabayashi Y; Nakatani T; Sakagami J; Yamagami T
    Cancer; 2008 Sep; 113(6):1362-9. PubMed ID: 18661511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic bone marrow transplantation after L-asparaginase-induced pancreatitis in a patient with acute lymphoblastic leukemia.
    Yamada Y; Ito K; Watanabe Y; Nosaka K; Horikawa K; Hidaka M; Kawano F; Sasaki Y; Mitsuya H; Asou N
    Leuk Res; 2008 Dec; 32(12):1944-6. PubMed ID: 18502503
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute pancreatitis in children with acute lymphoblastic leukemia treated with L-asparaginase.
    Flores-Calderón J; Exiga-Gonzaléz E; Morán-Villota S; Martín-Trejo J; Yamamoto-Nagano A
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):790-3. PubMed ID: 19770681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
    Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
    Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
    Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
    Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
    Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased serum trypsin and elastase-1 levels in patients undergoing L-asparaginase therapy.
    Shimizu T; Yamashiro Y; Igarashi J; Fujita H; Ishimoto K
    Eur J Pediatr; 1998 Jul; 157(7):561-3. PubMed ID: 9686816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow oedema and aseptic osteonecrosis in children and adolescents with acute lymphoblastic leukaemia or non-Hodgkin-lymphoma treated with hyperbaric-oxygen-therapy (HBO): an approach to cure? -- BME/AON and hyperbaric oxygen therapy as a treatment modality.
    Bernbeck B; Christaras A; Krauth K; Lentrodt S; Strelow H; Schaper J; Janssen G; Mödder U; Göbel U
    Klin Padiatr; 2004; 216(6):370-8. PubMed ID: 15565553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
    Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
    Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ureteral obstruction caused by L-asparaginase-induced pancreatitis in a child with acute lymphoblastic leukemia.
    Chen CH; Lu MY; Lin KH; Lin DT; Peng SF; Jou ST
    J Formos Med Assoc; 2004 May; 103(5):380-4. PubMed ID: 15216406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.